<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer</dc:title>
  <dc:creator>SEYA, Tsukasa</dc:creator>
  <dc:creator>AKAZAWA, Takashi</dc:creator>
  <dc:creator>UEHORI, Junji</dc:creator>
  <dc:creator>MATSUMOTO, Misako</dc:creator>
  <dc:creator>AZUMA, Ichiro</dc:creator>
  <dc:creator>TOYOSHIMA, Kumao</dc:creator>
  <dc:contributor>SOMA, Gen-Ichiro (Editor)</dc:contributor>
  <dc:contributor>KUROKI, Masahide (Editor)</dc:contributor>
  <dc:contributor>FUKUSHIMA, Takeo (Editor)</dc:contributor>
  <dc:contributor>Society of Biotherapeutic Approaches (Funder/Sponsor)</dc:contributor>
  <dc:contributor>Annual Meeting of the Society of Biotherapeutic Approaches (6 ; Fukuoka 2002-12-07)</dc:contributor>
  <dc:relation>Anticancer research -- Anticancer res, ISSN 0250-7005, Vol. 23 (6A) , pp. 4369-4376</dc:relation>
  <dc:relation>Proceedings of the Sixth Meeting of the Society of Biotherapeutic Approaches</dc:relation>
  <dc:date>2003</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Conference Paper</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>International Institute of Anticancer Research</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>8 p. ; 46 ref</dc:format>
  <dc:subject xml:lang="fr">Adjuvant</dc:subject>
  <dc:subject xml:lang="fr">BCG</dc:subject>
  <dc:subject xml:lang="fr">Cancérologie</dc:subject>
  <dc:subject xml:lang="fr">Immunité naturelle</dc:subject>
  <dc:subject xml:lang="fr">Immunothérapie</dc:subject>
  <dc:subject xml:lang="fr">Paroi cellulaire</dc:subject>
  <dc:subject xml:lang="fr">RNA bicaténaire</dc:subject>
  <dc:subject xml:lang="fr">Squelette</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="fr">Tumeur maligne</dc:subject>
  <dc:subject xml:lang="fr">Récepteur TLR</dc:subject>
  <dc:subject xml:lang="en">Adjuvant</dc:subject>
  <dc:subject xml:lang="en">BCG</dc:subject>
  <dc:subject xml:lang="en">Cancerology</dc:subject>
  <dc:subject xml:lang="en">Natural immunity</dc:subject>
  <dc:subject xml:lang="en">Immunotherapy</dc:subject>
  <dc:subject xml:lang="en">Cell wall</dc:subject>
  <dc:subject xml:lang="en">Double stranded RNA</dc:subject>
  <dc:subject xml:lang="en">Skeleton</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="en">Malignant tumor</dc:subject>
  <dc:subject xml:lang="en">Toll like receptor</dc:subject>
  <dc:subject xml:lang="en">Adjuvants</dc:subject>
  <dc:subject xml:lang="en">BCG-cell wall skeleton</dc:subject>
  <dc:subject xml:lang="en">Toll-like receptor</dc:subject>
  <dc:subject xml:lang="en">double-stranded RNA</dc:subject>
  <dc:subject xml:lang="en">innate immunity</dc:subject>
  <dc:subject xml:lang="es">Coadyuvante</dc:subject>
  <dc:subject xml:lang="es">BCG</dc:subject>
  <dc:subject xml:lang="es">Cancerología</dc:subject>
  <dc:subject xml:lang="es">Inmunidad natural</dc:subject>
  <dc:subject xml:lang="es">Inmunoterapia</dc:subject>
  <dc:subject xml:lang="es">Pared celular</dc:subject>
  <dc:subject xml:lang="es">ARN bicatenario</dc:subject>
  <dc:subject xml:lang="es">Esqueleto</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject xml:lang="es">Tumor maligno</dc:subject>
  <dc:subject>002B04: Tumeurs / Tumors</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 15348952</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>